Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 April, 2015 07:22 IST
Aurobindo gains on USFDA approval for Oxacillin
Source: IRIS | 21 Jan, 2013, 11.47AM
Comments  |  Post Comment

Aurobindo Pharma, a mid-size pharmaceutical company, gained on Monday after it has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials and Oxacillin for Injection USP 10g/Vial pharmacy bulk package.

Oxacillin for Injection USP is a sterile semisynthetic penicillin (SSP) indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.

Shares of the company are trading at Rs 195.70, up Rs 3.1, or 1.61% at the Bombay Stock Exchange (BSE) on Monday at 11:42 a.m.

The scrip has touched an intra-day high of Rs 196.70 and low of Rs 193.10. The total volume of shares traded at the BSE is 105,697.

In the earlier session, the shares gained 2.15%, or Rs 4.05, at Rs 192.60. Currently, the stock is trading down 4.49% from its 52-week high of Rs 204.90 and above 104.81% over the 52-week low of Rs 95.55.



Share Price Movement
Period Price
in Rs
Gain/(Loss)
in Rs in %
1 Week 184.55 8.05 4.36
1 Month 195.10 (2.50) (1.28)
3 Months 156.80 35.80 22.83
6 Months 108.40 84.20 77.68
1 Year 100.10 92.50 92.41
Note: Based on previous day closing price.


Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Infosys expects FY16 revenue to grow 10-12% - 24-Apr-2015 15:33
Infosys to acquire Kallidus for USD 120 mn - 24-Apr-2015 15:00
Infosys Q4 misses estimates; profit falls 4.7% sequentially - 24-Apr-2015 14:53
GPT Infraprojects bags order worth Rs 1.29 bn - 24-Apr-2015 13:07
IL&FS Engineering wins order worth Rs 3.26 bn from BMRCL - 24-Apr-2015 12:57
Rel Capital Asset Management in strategic alliance with Samsung Asset Management - 24-Apr-2015 10:53
Suven Life secures five product patents for NCEs - 24-Apr-2015 10:27
Advent, Temasek to buy CG's consumer electricals unit - 24-Apr-2015 10:01
Cairn India swings to Q4 loss on lower oil prices, exceptional item - 23-Apr-2015 19:09
IDBI Bank signs MoU with Bajaj Allianz General Insurance Company - 23-Apr-2015 18:54
IDBI Bank signs MoU with Bajaj Allianz General Insurance - 23-Apr-2015 18:21
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer